NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
4.150
+0.060 (1.47%)
At close: Dec 5, 2025, 4:00 PM EST
4.220
+0.070 (1.69%)
After-hours: Dec 5, 2025, 7:45 PM EST
NanoVibronix Employees
NanoVibronix had 31 employees as of December 31, 2024. The number of employees increased by 15 or 93.75% compared to the previous year.
Employees
31
Change (1Y)
15
Growth (1Y)
93.75%
Revenue / Employee
$86,613
Profits / Employee
-$147,839
Market Cap
4.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NAOV News
- 16 days ago - NanoVibronix Issues Letter to Shareholders - Business Wire
- 2 months ago - NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities - Business Wire
- 2 months ago - NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
- 2 months ago - NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio - Business Wire
- 3 months ago - NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology - Business Wire
- 4 months ago - NanoVibronix Announces Reverse Stock Split - Business Wire
- 5 months ago - NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock - Business Wire
- 5 months ago - NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation - Business Wire